{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:43:31Z","timestamp":1793043811038,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1208\/s12249-018-1208-8","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T16:45:57Z","timestamp":1547052357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System"],"prefix":"10.1208","volume":"20","author":[{"given":"Chune","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jconrel.2016.08.023","volume":"244","author":"K Hirota","year":"2016","unstructured":"Hirota K, Doty AC, Ackermann R, Zhou J, Olsen KF, Feng MR, et al. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation. J Control Release. 2016;244:302\u201313. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2016.08.023\n\n.","journal-title":"J Control Release"},{"issue":"10","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.actbio.2014.06.018","volume":"10","author":"F Qi","year":"2014","unstructured":"Qi F, Wu J, Yang TY, Ma GH, Su ZG. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification. Acta Biomater. 2014;10(10):4247\u201356. \nhttps:\/\/doi.org\/10.1016\/j.actbio.2014.06.018\n\n.","journal-title":"Acta Biomater"},{"issue":"1\u20132","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2015.01.008","volume":"480","author":"C Martin-Sabroso","year":"2015","unstructured":"Martin-Sabroso C, Fraguas-Sanchez AI, Aparicio-Blanco J, Cano-Abad MF, Torres-Suarez AI. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles. Int J Pharm. 2015;480(1\u20132):27\u201336. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2015.01.008\n\n.","journal-title":"Int J Pharm"},{"issue":"1","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2012.10.015","volume":"165","author":"ANF Versypt","year":"2013","unstructured":"Versypt ANF, Pack DW, Braatz RD. Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres - a review. J Control Release. 2013;165(1):29\u201337. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2012.10.015\n\n.","journal-title":"J Control Release"},{"key":"1208_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biomaterials.2017.02.006","volume":"124","author":"T Peters","year":"2017","unstructured":"Peters T, Kim SW, Castro V, Stingl K, Strasser T, Bolz S, et al. Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats. Biomaterials. 2017;124:157\u201368. \nhttps:\/\/doi.org\/10.1016\/j.biomaterials.2017.02.006\n\n.","journal-title":"Biomaterials"},{"issue":"4","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1208\/s12249-011-9694-y","volume":"12","author":"JH Ahn","year":"2011","unstructured":"Ahn JH, Park EJ, Lee HS, Lee KC, Na DH. Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly (lactide-co-glycolide) delivery systems. AAPS PharmSciTech. 2011;12(4):1220\u20136. \nhttps:\/\/doi.org\/10.1208\/s12249-011-9694-y\n\n.","journal-title":"AAPS PharmSciTech"},{"key":"1208_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejpb.2017.02.021","volume":"115","author":"H Wang","year":"2017","unstructured":"Wang H, Zhang GX, Ma XQ, Liu YH, Feng J, Park K, et al. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Eur J Pharm Biopharm. 2017;115:177\u201385. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2017.02.021\n\n.","journal-title":"Eur J Pharm Biopharm"},{"key":"1208_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.colsurfb.2017.12.040","volume":"163","author":"L Chen","year":"2017","unstructured":"Chen L, Mei L, Feng D, Huang D, Tong X, Pan X, et al. Anhydrous reverse micelle lecithin nanoparticles\/PLGA composite microspheres for long-term protein delivery with reduced initial burst. Colloid Surf B. 2017;163:146\u201354. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2017.12.040\n\n.","journal-title":"Colloid Surf B"},{"issue":"2","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2010.05.011","volume":"146","author":"ML Ye","year":"2010","unstructured":"Ye ML, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146(2):241\u201360. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2010.05.011\n\n.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijpharm.2016.01.020","volume":"499","author":"F Ramazani","year":"2016","unstructured":"Ramazani F, Chen WL, van Nostrum CF, Storm G, Kiessling F, Lammers T, et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges. Int J Pharm. 2016;499(1\u20132):358\u201367. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.020\n\n.","journal-title":"Int J Pharm"},{"issue":"7","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jps.21176","volume":"97","author":"ML Houchin","year":"2008","unstructured":"Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci. 2008;97(7):2395\u2013404. \nhttps:\/\/doi.org\/10.1002\/jps.21176\n\n.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijpharm.2011.06.041","volume":"416","author":"XG Wen","year":"2011","unstructured":"Wen XG, Peng XS, Fu H, Dong YX, Han K, Su JF, et al. Preparation and in vitro evaluation of silk fibroin microspheres produced by a novel ultra-fine particle processing system. Int J Pharm. 2011;416(1):195\u2013201. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2011.06.041\n\n.","journal-title":"Int J Pharm"},{"key":"1208_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.colsurfb.2015.05.001","volume":"132","author":"CE Zhu","year":"2015","unstructured":"Zhu CE, Huang Y, Zhang XY, Mei LL, Pan X, Li G, et al. Comparative studies on exenatide-loaded poly (D,L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying. Colloid Surf B. 2015;132:103\u201310. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2015.05.001\n\n.","journal-title":"Colloid Surf B"},{"issue":"11","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1016\/j.xphs.2017.07.010","volume":"106","author":"ZW Huang","year":"2017","unstructured":"Huang ZW, Chen XN, Fu H, Wen XG, Ma C, Zhang JW, et al. Formation mechanism and in vitro evaluation of risperidone-containing PLGA microspheres fabricated by ultrafine particle processing system. J Pharm Sci. 2017;106(11):3363\u201371. \nhttps:\/\/doi.org\/10.1016\/j.xphs.2017.07.010\n\n.","journal-title":"J Pharm Sci"},{"key":"1208_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2017.02.005","volume":"187","author":"RJ Mentz","year":"2017","unstructured":"Mentz RJ, Bethel MA, Gustavson S, Thompson VP, Pagidipati NJ, Buse JB, et al. Baseline characteristics of patients enrolled in the exenatide study of cardiovascular event lowering (EXSCEL). Am Heart J. 2017;187:1\u20139. \nhttps:\/\/doi.org\/10.1016\/j.ahj.2017.02.005\n\n.","journal-title":"Am Heart J"},{"issue":"10085","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(17)30058-2\n\n.","journal-title":"Lancet"},{"issue":"7","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3109\/03639045.2015.1107090","volume":"42","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhong Y, Hu M, Xiang NX, Fu Y, Gong T, et al. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes. Drug Dev Ind Pharm. 2016;42(7):1042\u20139. \nhttps:\/\/doi.org\/10.3109\/03639045.2015.1107090\n\n.","journal-title":"Drug Dev Ind Pharm"},{"key":"1208_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2017.01.023","volume":"249","author":"R Ni","year":"2017","unstructured":"Ni R, Muenster U, Zhao J, Zhang L, Becker-Pelster EM, Rosenbruch M, et al. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization. J Control Release. 2017;249:11\u201322. \nhttps:\/\/doi.org\/10.1016\/j.jconrel.2017.01.023\n\n.","journal-title":"J Control Release"},{"issue":"2","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1006\/abio.1999.4320","volume":"277","author":"JT Pelton","year":"2000","unstructured":"Pelton JT, McLean LR. Spectroscopic methods for analysis of protein secondary structure. Anal Biochem. 2000;277(2):167\u201376. \nhttps:\/\/doi.org\/10.1006\/abio.1999.4320\n\n.","journal-title":"Anal Biochem"},{"key":"1208_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.colsurfb.2016.08.032","volume":"147","author":"PX Wang","year":"2016","unstructured":"Wang PX, Wang Q, Ren TY, Gong HY, Gou JX, Zhang Y, et al. Effects of Pluronic F127-PEG multi-gel-core on the release profile and pharmacodynamics of exenatide loaded in PLGA microspheres. Colloid Surf B. 2016;147:360\u20137. \nhttps:\/\/doi.org\/10.1016\/j.colsurfb.2016.08.032\n\n.","journal-title":"Colloid Surf B"},{"issue":"1\u20132","key":"1208_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2015.12.045","volume":"499","author":"Z Guo","year":"2016","unstructured":"Guo Z, Yin XZ, Liu CB, Wu L, Zhu WF, Shao Q, et al. Microstructural investigation using synchrotron radiation X-ray microtomography reveals taste-masking mechanism of acetaminophen microspheres. Int J Pharm. 2016;499(1\u20132):47\u201357. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2015.12.045\n\n.","journal-title":"Int J Pharm"},{"issue":"6","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s11095-013-1262-6","volume":"31","author":"F Qi","year":"2014","unstructured":"Qi F, Wu J, Hao DX, Yang TY, Ren Y, Ma GH, et al. Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres. Pharm Res. 2014;31(6):1566\u201374. \nhttps:\/\/doi.org\/10.1007\/s11095-013-1262-6\n\n.","journal-title":"Pharm Res"},{"issue":"2","key":"1208_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.vascn.2011.04.004","volume":"64","author":"YQ Lin","year":"2011","unstructured":"Lin YQ, Khetarpal R, Zhang YL, Song HC, Li SS. Combination of ELISA and dried blood spot technique for the quantification of large molecules using exenatide as a model. J Pharmacol Toxicol Methods. 2011;64(2):124\u20138. \nhttps:\/\/doi.org\/10.1016\/j.vascn.2011.04.004\n\n.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"12","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1177\/0091270008323750","volume":"48","author":"PA Kothare","year":"2008","unstructured":"Kothare PA, Linnebjerg H, Isaka Y, Uenaka K, Yamamura A, Yeo KP, et al. Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus. J Clin Pharmacol. 2008;48(12):1389\u201399. \nhttps:\/\/doi.org\/10.1177\/0091270008323750\n\n.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"1208_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejpb.2005.12.012","volume":"63","author":"S Furtado","year":"2006","unstructured":"Furtado S, Abramson D, Simhkay L, Wobbekind D, Mathlowitz E. Subcutaneous delivery of insulin loaded poly (fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats. Eur J Pharm Biopharm. 2006;63(2):229\u201336. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2005.12.012\n\n.","journal-title":"Eur J Pharm Biopharm"},{"key":"1208_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.peptides.2013.06.005","volume":"46","author":"JM Xuan","year":"2013","unstructured":"Xuan JM, Lin YL, Huang JB, Yuan F, Li XQ, Lu Y, et al. Exenatide-loaded PLGA microspheres with improved glycemic control: In vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats. Peptides. 2013;46:172\u20139. \nhttps:\/\/doi.org\/10.1016\/j.peptides.2013.06.005\n\n.","journal-title":"Peptides"},{"issue":"33","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1016\/j.biomaterials.2013.07.040","volume":"34","author":"JY Kim","year":"2013","unstructured":"Kim JY, Lee H, Oh KS, Kweon S, Jeon OC, Byun Y, et al. Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus. Biomaterials. 2013;34(33):8444\u20139. \nhttps:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.040\n\n.","journal-title":"Biomaterials"},{"issue":"3","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ejpb.2014.08.004","volume":"88","author":"KS Oh","year":"2014","unstructured":"Oh KS, Kim JY, Yoon BD, Lee M, Kim H, Kim M, et al. Sol-gel transition of nanoparticles\/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus. Eur J Pharm Biopharm. 2014;88(3):664\u20139. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2014.08.004\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1208_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ijpharm.2017.05.019","volume":"531","author":"LW Fang","year":"2017","unstructured":"Fang LW, Yin XZ, Wu L, He YP, He YZ, Qin W, et al. Classification of microcrystalline celluloses via structures of individual particles measured by synchrotron radiation X-ray micro-computed tomography. Int J Pharm. 2017;531(2):658\u201367. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.019\n\n.","journal-title":"Int J Pharm"},{"key":"1208_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.partic.2016.05.011","volume":"30","author":"XJ Ju","year":"2017","unstructured":"Ju XJ, Wang XX, Liu Z, Xie R, Wang W, Chu LY. Red-blood-cell-shaped chitosan microparticles prepared by electrospraying. Particuology. 2017;30:151\u20137. \nhttps:\/\/doi.org\/10.1016\/j.partic.2016.05.011\n\n.","journal-title":"Particuology"},{"issue":"1\u20132","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0168-3659(03)00328-6","volume":"92","author":"J Panyam","year":"2003","unstructured":"Panyam J, Dali MA, Sahoo SK, Ma WX, Chakravarthi SS, Amidon GL, et al. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. J Control Release. 2003;92(1\u20132):173\u201387. \nhttps:\/\/doi.org\/10.1016\/S0168-3659(03)00328-6\n\n.","journal-title":"J Control Release"},{"issue":"2","key":"1208_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ijpharm.2015.11.018","volume":"496","author":"H Wang","year":"2015","unstructured":"Wang H, Zhang GX, Sui H, Liu YH, Park K, Wang WP. Comparative studies on the properties of glycyrrhetinic acid-loaded PLGA microparticles prepared by emulsion and template methods. Int J Pharm. 2015;496(2):723\u201331. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2015.11.018\n\n.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijpharm.2017.05.069","volume":"528","author":"PX Wang","year":"2017","unstructured":"Wang PX, Zhuo XZ, Chu W, Tang X. Exenatide-loaded microsphere\/ thermosensitive hydrogel long-acting delivery system with high drug bioactivity. Int J Pharm. 2017;528(1\u20132):62\u201375. \nhttps:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.069\n\n.","journal-title":"Int J Pharm"},{"issue":"51","key":"1208_CR34","doi-asserted-by":"publisher","first-page":"21495","DOI":"10.1073\/pnas.0907127106","volume":"106","author":"N Doshi","year":"2009","unstructured":"Doshi N, Zahr AS, Bhaskar S, Lahann J, Mitragotri S. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci U S A. 2009;106(51):21495\u20139. \nhttps:\/\/doi.org\/10.1073\/pnas.0907127106\n\n.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1208_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejpb.2016.11.008","volume":"113","author":"AC Doty","year":"2017","unstructured":"Doty AC, Zhang Y, Weinstein DG, Wang Y, Choi S, Qu W, et al. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions. Eur J Pharm Biopharm. 2017;113:24\u201333. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2016.11.008\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jps.24238","volume":"104","author":"SM Lim","year":"2015","unstructured":"Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy. J Pharm Sci. 2015;104(1):72\u201380. \nhttps:\/\/doi.org\/10.1002\/jps.24238\n\n.","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1208-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T05:10:03Z","timestamp":1592975403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1208-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1208-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee on Animal Experimentation at Sun Yat-sen University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"64"}}